HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
anaxirone
structure given in first source
Also Known As:
1,2,4-TGU; 1,2,4-triglycidyl urazol; NSC 332488; 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)-
Networked:
4
relevant articles (
0
outcomes,
4
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Triazoles: 1533
anaxirone: 4
Related Diseases
1.
Colorectal Neoplasms (Colorectal Cancer)
01/01/1994 - "
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) study.
"
01/01/1994 - "
Anaxirone is inactive in metastatic colorectal cancer.
"
01/01/1994 - "
Anaxirone, a rationally synthesised triepoxide derivative, was given to 46 patients with metastatic colorectal cancer.
"
2.
Neoplasms (Cancer)
06/01/1987 - "
Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group Study.
"
3.
Renal Cell Carcinoma (Grawitz Tumor)
06/01/1986 - "
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials group.
"
4.
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/01/1987 - "
Phase II trial of anaxirone in advanced non-small cell lung cancer.
"
5.
Carcinoma (Carcinomatosis)
06/01/1987 - "
Sixteen patients with advanced ovarian carcinoma were treated with anaxirone (1,2,4-triglycidylurazol, TGU), 600 mg/m2 every 4 weeks.
"
06/01/1987 - "
Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group Study.
"
Related Drugs and Biologics
1.
Cytostatic Agents